Royal Bank of Canada »

Vyne Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0k 1.3k 2.37
2023-09-30 $9.1k 2.2k 4.13
2023-06-30 $6.1k 1.4k 4.31

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Vyne Therapeutics

Cormorant Asset Management
Eventide Asset Management
Citadel Advisors
Soleus Capital Management
DSC Advisors
Palo Alto Investors
AlphaCentric Advisors
Exome Asset Management
Fred Alger Management
Vanguard Group
Millennium Management
Hrt Financial
Us Bancorp
Bank of America Corporation
Royal Bank of Canada

View all funds holding Vyne Therapeutics